Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 396

1.

Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the Children's Oncology Group AHEP 0731 Liver Tumor Committee.

Weldon CB, Madenci AL, Tiao GM, Dunn SP, Langham MR, McGahren ED, Ranganathan S, López-Terrada DH, Finegold MJ, Malogolowkin MH, Piao J, Huang L, Krailo MD, Meyers RL, Katzenstein HM.

J Pediatr Surg. 2019 May 11. pii: S0022-3468(19)30347-1. doi: 10.1016/j.jpedsurg.2019.05.004. [Epub ahead of print]

PMID:
31126688
2.

Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation.

Haines K, Sarabia SF, Alvarez KR, Tomlinson G, Vasudevan SA, Heczey AA, Roy A, Finegold MJ, Parsons DW, Plon SE, López-Terrada D.

Pediatr Blood Cancer. 2019 Jul;66(7):e27745. doi: 10.1002/pbc.27745. Epub 2019 Apr 11.

PMID:
30977242
3.

Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.

Katzenstein HM, Langham MR, Malogolowkin MH, Krailo MD, Towbin AJ, McCarville MB, Finegold MJ, Ranganathan S, Dunn S, McGahren ED, Tiao GM, O'Neill AF, Qayed M, Furman WL, Xia C, Rodriguez-Galindo C, Meyers RL.

Lancet Oncol. 2019 May;20(5):719-727. doi: 10.1016/S1470-2045(18)30895-7. Epub 2019 Apr 8. Erratum in: Lancet Oncol. 2019 May;20(5):e243.

PMID:
30975630
4.

Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease.

Amano H, Chaudhury A, Rodriguez-Aguayo C, Lu L, Akhanov V, Catic A, Popov YV, Verdin E, Johnson H, Stossi F, Sinclair DA, Nakamaru-Ogiso E, Lopez-Berestein G, Chang JT, Neilson JR, Meeker A, Finegold M, Baur JA, Sahin E.

Cell Metab. 2019 Jun 4;29(6):1274-1290.e9. doi: 10.1016/j.cmet.2019.03.001. Epub 2019 Mar 28.

PMID:
30930169
5.

Extrahepatic Nonreticuloendothelial Siderosis Is Not Specific to Gestational Alloimmune Liver Disease.

Wu H, Ferguson W, Castro E, Kearney D, Finegold M, Patel K.

Pediatr Dev Pathol. 2019 Feb 5:1093526619826429. doi: 10.1177/1093526619826429. [Epub ahead of print]

PMID:
30722724
6.

Predisposing Conditions to Pediatric Hepatocellular Carcinoma and Association With Outcomes: Single-center Experience.

Cowell E, Patel K, Heczey A, Finegold M, Venkatramani R, Wu H, López-Terrada D, Miloh T.

J Pediatr Gastroenterol Nutr. 2019 May;68(5):695-699. doi: 10.1097/MPG.0000000000002285.

PMID:
30676520
7.

Identification of Polycystic Kidney Disease 1 Like 1 Gene Variants in Children With Biliary Atresia Splenic Malformation Syndrome.

Berauer JP, Mezina AI, Okou DT, Sabo A, Muzny DM, Gibbs RA, Hegde MR, Chopra P, Cutler DJ, Perlmutter DH, Bull LN, Thompson RJ, Loomes KM, Spinner NB, Rajagopalan R, Guthery SL, Moore B, Yandell M, Harpavat S, Magee JC, Kamath BM, Molleston JP, Bezerra JA, Murray KF, Alonso EM, Rosenthal P, Squires RH, Wang KS, Finegold MJ, Russo P, Sherker AH, Sokol RJ, Karpen SJ; Childhood Liver Disease Research Network (ChiLDReN).

Hepatology. 2019 Jan 21. doi: 10.1002/hep.30515. [Epub ahead of print]

PMID:
30664273
8.

Growth Factor-Independent 1 Is a Tumor Suppressor Gene in Colorectal Cancer.

Chen MS, Lo YH, Chen X, Williams CS, Donnelly JM, Criss ZK 2nd, Patel S, Butkus JM, Dubrulle J, Finegold MJ, Shroyer NF.

Mol Cancer Res. 2019 Mar;17(3):697-708. doi: 10.1158/1541-7786.MCR-18-0666. Epub 2019 Jan 3.

PMID:
30606770
9.

Atypical Hepatic Mesenchymal Hamartoma: Histologic Appearance, Immunophenotype, and Molecular Findings.

El Demellawy D, Lee JY, McDonell L, Dyment DA, Knisely AS, McGowan-Jordan J, Ngan B, Finegold M, Kapur RP, Nasr A.

Pediatr Dev Pathol. 2018 Nov 29:1093526618806750. doi: 10.1177/1093526618806750. [Epub ahead of print]

PMID:
30497332
10.

Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.

Kodama T, Yi J, Newberg JY, Tien JC, Wu H, Finegold MJ, Kodama M, Wei Z, Tamura T, Takehara T, Johnson RL, Jenkins NA, Copeland NG.

Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):E10417-E10426. doi: 10.1073/pnas.1808968115. Epub 2018 Oct 16.

11.

Inflammation, Active Fibroplasia, and End-stage Fibrosis in 172 Biliary Atresia Remnants Correlate Poorly With Age at Kasai Portoenterostomy, Visceral Heterotaxy, and Outcome.

Bove KE, Thrasher AD, Anders R, Chung CT, Cummings OW, Finegold MJ, Finn L, Ranganathan S, Kim GE, Lovell M, Magid MS, Melin-Aldana H, Russo P, Shehata B, Wang L, White F, Chen Z, Spino C, Magee JC.

Am J Surg Pathol. 2018 Dec;42(12):1625-1635. doi: 10.1097/PAS.0000000000001146.

PMID:
30247160
12.

Hepatic Steatosis Is Prevalent Following Orthotopic Liver Transplantation in Children With Cystic Fibrosis.

Cortes-Santiago N, Leung DH, Castro E, Finegold M, Wu H, Patel KR.

J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):96-103. doi: 10.1097/MPG.0000000000002154.

PMID:
30234762
13.

Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis.

Kim KH, Choi JM, Li F, Arizpe A, Wooton-Kee CR, Anakk S, Jung SY, Finegold MJ, Moore DD.

Endocrinology. 2018 Jun 1;159(6):2435-2446. doi: 10.1210/en.2018-00110.

PMID:
29718219
14.

Factors Influencing Time-to-diagnosis of Biliary Atresia.

Harpavat S, Lupo PJ, Liwanag L, Hollier J, Brandt ML, Finegold MJ, Shneider BL.

J Pediatr Gastroenterol Nutr. 2018 Jun;66(6):850-856. doi: 10.1097/MPG.0000000000001887.

15.

Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration.

Lu L, Finegold MJ, Johnson RL.

Exp Mol Med. 2018 Jan 5;50(1):e423. doi: 10.1038/emm.2017.205.

16.

De novo hepatocellular carcinoma post-multivisceral transplantation in a child.

Tran P, Zhou S, Wang L, Finegold M, Mascarenhas L, Alexopolous S, Genyk Y, Kerkar N.

Pediatr Transplant. 2017 Nov;21(7). doi: 10.1111/petr.12991. Epub 2017 Jul 27. Erratum in: Pediatr Transplant. 2017 Dec 14;:.

PMID:
29024228
17.

Post-transplant Recurrent Bile Salt Export Pump Disease: A Form of Antibody-mediated Graft Dysfunction and Utilization of C4d.

Patel KR, Harpavat S, Finegold M, Eldin K, Hicks J, Firan M, Keitel V, Kubitz R, Wu H.

J Pediatr Gastroenterol Nutr. 2017 Oct;65(4):364-369. doi: 10.1097/MPG.0000000000001653.

PMID:
28945205
18.

Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.

O'Neill AF, Towbin AJ, Krailo MD, Xia C, Gao Y, McCarville MB, Meyers RL, McGahren ED, Tiao GM, Dunn SP, Langham MR Jr, Weldon CB, Finegold MJ, Ranganathan S, Furman WL, Malogolowkin M, Rodriguez-Galindo C, Katzenstein HM.

J Clin Oncol. 2017 Oct 20;35(30):3465-3473. doi: 10.1200/JCO.2017.73.5654. Epub 2017 Sep 11.

19.

A Rare Phenotype of Alpha-1-Antitrypsin Deficiency Owing to PI*IS in a Newborn With Liver Disease.

Huang AC, Perez C, Felipez L, Chamyan G, Finegold MJ, Hernandez E.

J Pediatr Gastroenterol Nutr. 2017 Nov;65(5):e112-e113. doi: 10.1097/MPG.0000000000001716. No abstract available.

PMID:
28837509
20.

Adult Mouse Liver Contains Two Distinct Populations of Cholangiocytes.

Li B, Dorrell C, Canaday PS, Pelz C, Haft A, Finegold M, Grompe M.

Stem Cell Reports. 2017 Aug 8;9(2):478-489. doi: 10.1016/j.stemcr.2017.06.003. Epub 2017 Jul 6.

21.

Contemporary Evaluation of the Pediatric Liver Biopsy.

Schady DA, Finegold MJ.

Gastroenterol Clin North Am. 2017 Jun;46(2):233-252. doi: 10.1016/j.gtc.2017.01.013. Review.

PMID:
28506363
22.

Hepatic Hilar Lymph Node Reactivity at Kasai Portoenterostomy for Biliary Atresia: Correlations With Age, Outcome, and Histology of Proximal Biliary Remnant.

Bove KE, Sheridan R, Fei L, Anders R, Chung CT, Cummings OW, Finegold MJ, Finn L, Ranganathan S, Kim G, Lovell M, Magid MS, Melin-Aldana H, Russo P, Shehata B, Wang L, White F, Chen Z, Spino C, Magee JC.

Pediatr Dev Pathol. 2018 Jan-Feb;21(1):29-40. doi: 10.1177/1093526617707851. Epub 2017 May 5.

PMID:
28474973
23.

Pediatric Mesenchymal Hamartomas of the Liver can Show Both Foregut and Hindgut Phenotype.

Wu H, Ferguson W, Castro E, Finegold M, Patel K.

Pediatr Dev Pathol. 2017 Nov-Dec;20(6):490-497. doi: 10.1177/1093526617706817. Epub 2017 May 4.

PMID:
28468559
24.

Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.

Katzenstein HM, Furman WL, Malogolowkin MH, Krailo MD, McCarville MB, Towbin AJ, Tiao GM, Finegold MJ, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Rodriguez-Galindo C, Meyers RL.

Cancer. 2017 Jun 15;123(12):2360-2367. doi: 10.1002/cncr.30591. Epub 2017 Feb 17.

25.

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Kettner NM, Voicu H, Finegold MJ, Coarfa C, Sreekumar A, Putluri N, Katchy CA, Lee C, Moore DD, Fu L.

Cancer Cell. 2016 Dec 12;30(6):909-924. doi: 10.1016/j.ccell.2016.10.007. Epub 2016 Nov 23.

26.

Pathology of the liver in children: Where would I (we) be without "Pepper"?

Finegold MJ.

Semin Diagn Pathol. 2016 Nov;33(6):367-376. doi: 10.1053/j.semdp.2016.08.002. Epub 2016 Sep 4.

PMID:
27793410
27.

Key Histopathologic Features of Liver Biopsies That Distinguish Biliary Atresia From Other Causes of Infantile Cholestasis and Their Correlation With Outcome: A Multicenter Study.

Russo P, Magee JC, Anders RA, Bove KE, Chung C, Cummings OW, Finegold MJ, Finn LS, Kim GE, Lovell MA, Magid MS, Melin-Aldana H, Ranganathan S, Shehata BM, Wang LL, White FV, Chen Z, Spino C; Childhood Liver Disease Research Network (ChiLDReN).

Am J Surg Pathol. 2016 Dec;40(12):1601-1615.

28.

Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups.

Sumazin P, Chen Y, Treviño LR, Sarabia SF, Hampton OA, Patel K, Mistretta TA, Zorman B, Thompson P, Heczey A, Comerford S, Wheeler DA, Chintagumpala M, Meyers R, Rakheja D, Finegold MJ, Tomlinson G, Parsons DW, López-Terrada D.

Hepatology. 2017 Jan;65(1):104-121. doi: 10.1002/hep.28888. Epub 2016 Nov 29.

PMID:
27775819
29.

Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant β-catenin.

Comerford SA, Hinnant EA, Chen Y, Bansal H, Klapproth S, Rakheja D, Finegold MJ, Lopez-Terrada D, O'Donnell KA, Tomlinson GE, Hammer RE.

JCI Insight. 2016 Oct 6;1(16):e88549. doi: 10.1172/jci.insight.88549.

30.

The mucosal microbiota in a young child with severe non-Helicobacter gastritis.

Preidis GA, Luna RA, Hollister EB, Schady D, Gao C, Finegold MJ, Versalovic J, Shulman RJ.

Therap Adv Gastroenterol. 2016 Sep;9(5):749-51. doi: 10.1177/1756283X16653582. Epub 2016 Jun 14. No abstract available.

31.

Dual Role of the Adaptive Immune System in Liver Injury and Hepatocellular Carcinoma Development.

Endig J, Buitrago-Molina LE, Marhenke S, Reisinger F, Saborowski A, Schütt J, Limbourg F, Könecke C, Schreder A, Michael A, Misslitz AC, Healy ME, Geffers R, Clavel T, Haller D, Unger K, Finegold M, Weber A, Manns MP, Longerich T, Heikenwälder M, Vogel A.

Cancer Cell. 2016 Aug 8;30(2):308-323. doi: 10.1016/j.ccell.2016.06.009. Epub 2016 Jul 28.

32.

Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients.

Karandikar UC, Crawford SE, Ajami NJ, Murakami K, Kou B, Ettayebi K, Papanicolaou GA, Jongwutiwes U, Perales MA, Shia J, Mercer D, Finegold MJ, Vinjé J, Atmar RL, Estes MK.

J Gen Virol. 2016 Sep;97(9):2291-300. doi: 10.1099/jgv.0.000545. Epub 2016 Jul 12.

33.

A universal system to select gene-modified hepatocytes in vivo.

Nygaard S, Barzel A, Haft A, Major A, Finegold M, Kay MA, Grompe M.

Sci Transl Med. 2016 Jun 8;8(342):342ra79. doi: 10.1126/scitranslmed.aad8166.

34.

Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma.

Kodama T, Newberg JY, Kodama M, Rangel R, Yoshihara K, Tien JC, Parsons PH, Wu H, Finegold MJ, Copeland NG, Jenkins NA.

Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3384-93. doi: 10.1073/pnas.1606876113. Epub 2016 May 31.

35.

Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.

Bissig-Choisat B, Kettlun-Leyton C, Legras XD, Zorman B, Barzi M, Chen LL, Amin MD, Huang YH, Pautler RG, Hampton OA, Prakash MM, Yang D, Borowiak M, Muzny D, Doddapaneni HV, Hu J, Shi Y, Gaber MW, Hicks MJ, Thompson PA, Lu Y, Mills GB, Finegold M, Goss JA, Parsons DW, Vasudevan SA, Sumazin P, López-Terrada D, Bissig KD.

J Hepatol. 2016 Aug;65(2):325-33. doi: 10.1016/j.jhep.2016.04.009. Epub 2016 Apr 23.

36.

Hepatoblastoma Arising in a Pigmented β-catenin-activated Hepatocellular Adenoma: Case Report and Review of the Literature.

Louie CY, Concepcion W, Park JK, Rangaswami A, Finegold MJ, Hazard FK.

Am J Surg Pathol. 2016 Jul;40(7):998-1003. doi: 10.1097/PAS.0000000000000652. Review.

PMID:
27096257
37.

Undifferentiated Embryonal Sarcoma of the Liver (UESL): A Single-Center Experience and Review of the Literature.

Techavichit P, Masand PM, Himes RW, Abbas R, Goss JA, Vasudevan SA, Finegold MJ, Heczey A.

J Pediatr Hematol Oncol. 2016 May;38(4):261-8. doi: 10.1097/MPH.0000000000000529. Review.

PMID:
26925712
38.

A Case of an 11-year-old With Cough, Diarrhea, and Findings of Concern in His Lungs and Spleen.

Darby JB, Rees CA, Bocchini CE, Cruz AT, Kellermayer R, Finegold MJ, Barlow SE.

Pediatrics. 2016 Mar;137(3):e20150155. doi: 10.1542/peds.2015-0155. Epub 2016 Feb 15.

39.

Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis.

Gomez-Ospina N, Potter CJ, Xiao R, Manickam K, Kim MS, Kim KH, Shneider BL, Picarsic JL, Jacobson TA, Zhang J, He W, Liu P, Knisely AS, Finegold MJ, Muzny DM, Boerwinkle E, Lupski JR, Plon SE, Gibbs RA, Eng CM, Yang Y, Washington GC, Porteus MH, Berquist WE, Kambham N, Singh RJ, Xia F, Enns GM, Moore DD.

Nat Commun. 2016 Feb 18;7:10713. doi: 10.1038/ncomms10713.

40.

Liver tumors in children with metabolic disorders.

Schady DA, Roy A, Finegold MJ.

Transl Pediatr. 2015 Oct;4(4):290-303. doi: 10.3978/j.issn.2224-4336.2015.10.08. Review.

41.

TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome.

Chen J, Yao ZX, Chen JS, Gi YJ, Muñoz NM, Kundra S, Herlong HF, Jeong YS, Goltsov A, Ohshiro K, Mistry NA, Zhang J, Su X, Choufani S, Mitra A, Li S, Mishra B, White J, Rashid A, Wang AY, Javle M, Davila M, Michaely P, Weksberg R, Hofstetter WL, Finegold MJ, Shay JW, Machida K, Tsukamoto H, Mishra L.

J Clin Invest. 2016 Feb;126(2):527-42. doi: 10.1172/JCI80937. Epub 2016 Jan 19.

42.

Newborn Direct or Conjugated Bilirubin Measurements As a Potential Screen for Biliary Atresia.

Harpavat S, Ramraj R, Finegold MJ, Brandt ML, Hertel PM, Fallon SC, Shepherd RW, Shneider BL.

J Pediatr Gastroenterol Nutr. 2016 Jun;62(6):799-803. doi: 10.1097/MPG.0000000000001097.

PMID:
26720765
43.

Reminiscences.

Finegold M.

Pediatr Dev Pathol. 2015 Nov-Dec;18(6):530. doi: 10.2350/15-10-1720-OA.1. Epub 2015 Dec 23. No abstract available.

PMID:
26699840
44.

P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients.

Maynard JP, Lee JS, Sohn BH, Yu X, Lopez-Terrada D, Finegold MJ, Goss JA, Thevananther S.

Oncotarget. 2015 Dec 1;6(38):41162-79. doi: 10.18632/oncotarget.6240.

45.

Elevated copper impairs hepatic nuclear receptor function in Wilson's disease.

Wooton-Kee CR, Jain AK, Wagner M, Grusak MA, Finegold MJ, Lutsenko S, Moore DD.

J Clin Invest. 2015 Sep;125(9):3449-60. doi: 10.1172/JCI78991. Epub 2015 Aug 4.

46.

Hepatocellular carcinoma associated with tight-junction protein 2 deficiency.

Zhou S, Hertel PM, Finegold MJ, Wang L, Kerkar N, Wang J, Wong LJ, Plon SE, Sambrotta M, Foskett P, Niu Z, Thompson RJ, Knisely AS.

Hepatology. 2015 Dec;62(6):1914-6. doi: 10.1002/hep.27872. Epub 2015 Jun 19. No abstract available.

47.

An infant with a diagnostically challenging hepatic teratoma, hypofibrinogenemia, and adrenal neuroblastoma: case report.

Fried I, Rom-Gross E, Finegold M, Simanovsky N, Revel-Vilk S, Ben-Neriah Z, Weintraub M, Pappo O, Meir K.

Pediatr Dev Pathol. 2015 May-Jun;18(3):251-6. doi: 10.2350/13-08-1361-CR.1. Epub 2015 Mar 10.

PMID:
25756389
48.

Methylation status of the chromosome arm 19q MicroRNA cluster in sporadic and androgenetic-Biparental mosaicism-associated hepatic mesenchymal hamartoma.

Keller RB, Demellawy DE, Quaglia A, Finegold M, Kapur RP.

Pediatr Dev Pathol. 2015 May-Jun;18(3):218-27. doi: 10.2350/15-01-1600-OA.1. Epub 2015 Mar 9.

PMID:
25751191
49.

Focal nodular hyperplasia in children: an institutional experience with review of the literature.

Ma IT, Rojas Y, Masand PM, Castro EC, Himes RW, Kim ES, Goss JA, Nuchtern JG, Finegold MJ, Thompson PA, Vasudevan SA.

J Pediatr Surg. 2015 Mar;50(3):382-7. doi: 10.1016/j.jpedsurg.2014.06.016. Epub 2014 Aug 27. Review.

PMID:
25746693
50.

Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis.

Dong B, Lee JS, Park YY, Yang F, Xu G, Huang W, Finegold MJ, Moore DD.

Nat Commun. 2015 Feb 9;6:5944. doi: 10.1038/ncomms6944.

Supplemental Content

Loading ...
Support Center